Benefit of ESP Peri Operative Analgesia for Live Liver Donor Transplantation
ESPLIVERDON
Improvement of Quality of Life After Live Liver Donation by ESP Peri Operative Analgesia
1 other identifier
interventional
24
1 country
1
Brief Summary
Liver donors have a significant risk to develop persistent and chronic pain around 20 to 30% affecting social and professional life (17%) up to 1 year after the surgery. To donate a part of liver is a beautiful gift reason why the pain relief must be improved. Meta-analysis showed that the best prevention against post operative chronic pain are the techniques blocking the pain signal (regional anaesthesia) Patients after liver donation are still in pain even in 2020 with the best multimodal analgesia medications. Erector sinae Plane Block (ESP) ESP will block the signal and improve the pain relief we hope to demonstrate that it will reduce the risk to develop post operative chronic pain and improve the quality of recovery and the quality of life after liver donation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2020
CompletedFirst Posted
Study publicly available on registry
September 30, 2020
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2024
CompletedNovember 15, 2022
November 1, 2022
3.1 years
September 20, 2020
November 11, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
quality of pain relief at rest
Visual analgesic score at rest
from day 0 = day of surgery to day 180
quality of pain relief at mouvement
Visual analgesic score at mouvement
from day 0 = day of surgery to day 180
Secondary Outcomes (5)
Opioid consumption
from day 0 to 30 days after the day of surgery
Duration of hospitalisation
From day = 0 day of the surgery to day to discharge day 15 maximum
Quality of recovery
1 month after surgery
Patient satisfaction
1 month after the surgery
Quality of life (QOL) after donation
1 months and 3 months after surgery
Study Arms (2)
standard of care
NO INTERVENTIONPeri-operative analgesia by opioids
Peri operative regional analgesia
EXPERIMENTALPeri-operative analgesia by Continuous bilateral Erector Spinae Catheters
Interventions
Insertion of bilateral catheters in the intersfacia space of erector spinae muscle
Eligibility Criteria
You may qualify if:
- age more than 18 and less than 61
- Be volunteer to donate liver
- agree to participate to study and consent signed
- Risk of americain society of anesthesiologists score ASA from 1 to 5 score ASA must be 1 only
You may not qualify if:
- Use of chronic opioid before the surgery
- A diagnosis of chronic pain condition
- Contra indication to perform ESP catheter
- allergy to local anesthestics
- Depression or psychiatric diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VinMec INternational hospital
Hanoi, 100000, Vietnam
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of anesthesia and pain management - Anesthesiologist MD
Study Record Dates
First Submitted
September 20, 2020
First Posted
September 30, 2020
Study Start
November 1, 2020
Primary Completion
November 30, 2023
Study Completion
February 25, 2024
Last Updated
November 15, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share